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Abstract
Little is known about mammalian preRC stoichiometry, the number of preRCs on chromosomes, and how this relates to
replicon size and usage. We show here that, on average, each 100-kb of the mammalian genome contains a preRC
composed of approximately one ORC hexamer, 4–5 MCM hexamers, and 2 Cdc6. Relative to these subunits, ,0.35 total
molecules of the pre-Initiation Complex factor Cdc45 are present. Thus, based on ORC availability, somatic cells contain
,70,000 preRCs of this average total stoichiometry, although subunits may not be juxtaposed with each other. Except for
ORC, the chromatin-bound complement of preRC subunits is even lower. Cdc45 is present at very low levels relative to the
preRC subunits, but is highly stable, and the same limited number of stable Cdc45 molecules are present from the
beginning of S-phase to its completion. Efforts to artificially increase Cdc45 levels through ectopic expression block cell
growth. However, microinjection of excess purified Cdc45 into S-phase nuclei activates additional replication foci by three-
fold, indicating that Cdc45 functions to activate dormant preRCs and is rate-limiting for somatic replicon usage.
Paradoxically, although Cdc45 colocalizes in vivo with some MCM sites and is rate-limiting for DNA replication to occur,
neither Cdc45 nor MCMs colocalize with active replication sites. Embryonic metazoan chromatin consists of small replicons
that are used efficiently via an excess of preRC subunits. In contrast, somatic mammalian cells contain a low density of
preRCs, each containing only a few MCMs that compete for limiting amounts of Cdc45. This provides a molecular
explanation why, relative to embryonic replicon dynamics, somatic replicons are, on average, larger and origin efficiency
tends to be lower. The stable, continuous, and rate-limiting nature of Cdc45 suggests that Cdc45 contributes to the
staggering of replicon usage throughout S-phase, and that replicon activation requires reutilization of existing Cdc45 during
S-phase.
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Introduction
DNA replication initiates from chromatin-bound pre-Replica-
tion Complexes (preRCs). The Origin Recognition Complex
(ORC) nucleates preRC assembly on DNA [1], thus identifying
the target sequence for initiation. ORC recruits Cdt1 and Cdc6
[2,3,4], which facilitate loading of the hexameric Mini-Chromo-
some Maintenance (MCM) complex [5,6]. Cdc45, Mcm10, and
DNA polymerases are recruited [7,8], and DNA unwinding occurs
in a Cdc45- and MCM-dependent manner [9]. In yeast, Cdc45
and MCMs are also present at elongating forks [10] and required
for fork progression [11,12].
Xenopus laevis embryonic extracts replicate sperm chromatin very
efficiently, but in a sequence-independent manner from origins that
are spaced ,10–15-kb apart [13,14,15,16]. The distance between
these origins defines the replicon size, and these replicons initiate in
clusters in a staggered manner [13]. Each replicon/origin in the
Xenopus system contains approximately one ORC hexamer, two
Cdc6, two Mcm10, 1–2 Cdc45, and 20–50 MCM hexamers bound
to chromatin prior to S-phase [7,13,15,17,18,19]. Thus, each
embryonic replicon has one preRC of the above stoichiometry from
which to initiate DNA replication. Evidence suggests that Cdc45
binds and selects two of the many available MCM hexamers within
each preRC for functioning during unwinding, and Cdc45 is rate-
limiting for DNAreplication inembryonicextracts [17]. This excess
of MCMs for Cdc45 recruitment, along with frequent (10–15-kb)
spacing of preRCs, likely contributes to the high efficiency of DNA
replication in the embryonic system. Further, embryonic chromatin
has dormant origins, via the excess MCMs, whose functionality are
important during replicative stress [20].
In a study that mimicked passage of Xenopus embryonic extracts
through the mid-blastula transition toward a somatic state, replicon
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to result from a limiting concentration of a key replication factor
[15]. However, the preRC components analyzed were in excess in
the extracts [15] and the identity of a rate-limiting factor(s) affecting
replicon size remained elusive. Interestingly, one candidate for such
a limiting factor that was not analyzed in this prior study is Cdc45.
However, a later study indicated that Cdc45 is indeed rate-limiting
for embryonic extract DNA replication, but is present in excess in
the extracts, suggesting that it is not rate-limiting due to
stoichiometric issues [17]. Related to this, in S. cerevisiae yeast
Cdc45 appears to be present at similar stoichiometric ratios to
MCM and ORC subunits [21], but has been found to be rate-
limiting for DNA replication S. pombe yeast [22].
Mammalian somatic cells have very large replicons that vary from
,50-kb to 500-kb [23,24,25,26,27,28]. As in embryonic extracts,
mammalian replicons appear to replicate in clusters and in a
staggered manner [23,25]. However, mammalian origins are far less
efficient at firing relative to embryonic origins [27,29]. We predicted
that the biological characteristics of mammalian somatic replicon
size, usage, and origin efficiency might be derived at the molecular
level from unique characteristics of preRC distribution or subunit
availability that differs from embryonic extracts. Toward this end, we
used a systematic and overlapping approach to determine the
approximate stoichiometry and average genomic distribution of
mammalian preRCs. Our results show that significant differences
indeed exist between somatic cells and embryonic systems.
Mammalian ORC and MCM hexamers are much less abundant
in somatic cells, and Cdc45 protein levels are extremely low and
limiting for replicon usage in mammalian cells. These results provide
a molecular explanation for several biological characteristics of DNA
replication in mammalian cells, including why somatic replicon sizes
are large, origin efficiency is low, and replicon usage is staggered.
Results
Quantification method and antibody validity
The method behind our approach has been used effectively to
measure similar protein stoichiometries in yeast and Xenopus
[5,7,17,18,19,30,31]. In this method, the immunoblotting signal of
the protein of interest (but unknown molecular amount) derived
from a known number of cells is compared to purified known
amounts of the same protein (the standard). Several issues were
considered to mitigate potential difficulties in interpretations.
Purified standards were used such that the same species of preRC
subunit was compared to itself, but also compared across species.
Because post-translational modifications to proteins can alter
antibody recognition, we performed a heavily redundant analysis
to prevent erroneous conclusions that can be drawn from single
assays. When quantifying a preRC subunit in most cases, two or
more independent antibodies and two or more independent assays
on separate lysates were used (and averaged). Also, assays were
performed on multiple members of ORC and MCM hexamers
under the assumption that the relative stoichiometries obtained
would be 1:1 within each complex if present in hexamers (which
proved to be true). Antibodies (Table S1) were verified for
specificity on immunoblots (Fig. S1; note this figure is not for
quantitative comparisons). This overlapping and redundant
approach with multiple antibodies and immunoblots, against
multiple subunits predicted to be hexameric, generated a high
degree of confidence in the final measurements.
ORC subunit measurements
Whole-cell lysates from asynchronous CHO cells were com-
pared to purified CgOrc2, CgOrc4, or CgOrc5 in duplicate
immunoblots performed on separate CHO lysates. Representative
results with the ,ng quantities detected for each subunit are
shown in Figure 1A–C, with numerical results in Table S2. The
average total cellular level for CgOrc2 obtained with three
antibodies is 0.8, 1.0, and 0.8 ng per 10
5 CHO cells, while
CgOrc4 is 1.2 ng/10
5 cells. p60-Orc5 and p45-Orc5 are 0.7 and
1.2 ng/10
5 cells, respectively. The p45-Orc5 has been shown by
others to be an isoform of Orc5, called Orc5T (for truncated),
produced from alternative mRNA splicing [32]. When ORC
subunits/cell are calculated, there are ,7.5610
4 CgOrc2,
,14610
4 CgOrc4, ,7610
4 p60-CgOrc5, and ,16610
4 p45-
CgOrc5 in each cell. In terms of molecules per genomic region,
there are approximately 1 CgOrc2, 2 CgOrc4, 1 CgOrc5 (p60),
and 2–3 CgOrc5 (p45) per 100-kb. Although slightly discordant
from the 1:1 ratio expected for subunits in a hexamer, when the
chromatin-bound complement of each ORC subunit is consid-
ered, these ratios do approach unity (see below).
On average, 1 ORC hexamer exists per 100-kb in somatic cells,
which is significantly lower than on embryonic chromatin where
8–10 ORCs exist per 100-kb [13,15]. Based on such precedents,
we had anticipated that there would be more ORC in somatic
cells, which is why some of our quantitative blots contain standards
loaded at higher levels relative to the unknown lysates (for
example, see Fig. 1A, top and bottom anti-Orc2 assays, and the
Mcm2 analysis in Fig. 1D, middle panel, discussed later). Such
analyses place the comparisons slightly outside of the linear range
in those cases, but have been intentionally left in the figures to
illustrate that, had there been more ORC, it would clearly have
been evident.
We also analyzed lysates from human and murine cells (Fig.
S2A). HsOrc4 and MmOrc4, and HsOrc5, produced similar band
intensities to CgOrc4/5. Although MmOrc2 showed results
similar to CgOrc2, HsOrc2 in HeLa and Wilson cells with two
anti-Orc2 antibodies gave very strong signals relative to CgOrc2.
Our strain of HeLa cells also contains two forms of Orc2 (Fig.
S2A), possibly due to genomic rearrangements, alternative
splicing, or post-translational modifications. Although the com-
parison between CgOrc2 standard and HsOrc2 may give
erroneous results due to species differences, it is possible that
HsOrc2 is over-represented up to ten-fold in some cells. Indeed,
this might explain why 10 fold reduction of HsOrc2 allows
viability [33]. In the end, we conclude that MmOrc2 and
MmOrc4, and HsOrc4 and HsOrc5, are present at similar levels
to that in CHO cells.
MCM subunit measurements
We possessed purified full-length HsMcm2, HsMcm4,
HsMcm5, and HsMcm7. Species-specific comparisons dictated
that we analyze human cells, but we also analyzed CHO and 3T3
lysates. In order to mitigate potential problems with comparisons
between HsMCM standards and CgMCM subunits, we used a
redundant approach involving eight anti-MCM antibodies against
four MCM subunits, used on 14 immunoblots, to determine the
levels of MCMs per CHO cell. Further, we have cloned and
sequenced CgMcm6 and found it to be 96% identical at the amino
acid level with HsMcm6, confirming that mammalian MCMs are
highly conserved across species. Thus, the anti-MCM antibodies
used for these analyses need not have been generated against the
cognate mammalian species for obtaining useful quantitation data.
Lysates from asynchronous cells were analyzed for MCM levels
(Figure 1D–G). The average total amount for each MCM subunit
ranged from ,4–5.5 ng per 10
5 human cells. Signal intensities for
MCM subunits in CHO and 3T3 lysates were nearly identical to
those obtained with human cells in almost all of the immunoblots,
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quantities of MCM subunits. Each MCM subunit is present at
,3–4610
5 molecules per somatic cell, producing, on average,
,4–5 total molecules/100-kb of each MCM subunit (Table S2).
These MCM measurements indicate that mammalian cells
contain an ,1:1 ratio of each MCM subunit, consistent with the
complex being a hexamer of equal subunit representation.
Further, somatic cells contain significantly fewer MCM hexamers
on a per genomic region basis (,4–5/100-kb) compared to
embryonic chromatin (,200–500/100-kb). This equates to 40-100
fold fewer MCM hexamers available in total in somatic cells.
Consistent with our results, Knippers and colleagues [34]
determined (but did not show the data) that ,10
6 HsMcm3
molecules are present per HeLa cell, which is only 2–3 fold above
our estimations for Mcm2, 4, 5, and 7, but still vastly lower than
on embryonic chromatin.
Cdc6 and Cdc45 measurements
Several protein bands for Cdc6 and Cdc45 were recognized,
which likely represent post-translationally modified proteins.
Although mammalian Cdc6 is known to be modified by
phosphorylation and ubiquitinylation [35,36], and at least two
distinct protein bands have been shown to exist for mammalian
Cdc45 [37], we cannot be certain that all bands recognized are
indeed Cdc6 and Cdc45. However, for the purposes of
simplifying the quantitation and erring our estimates upward,
we determined the total amount of Cdc6 and Cdc45 based on the
sum of visible bands detected (and indicate the amounts of
Figure 1. Estimates of ORC and MCM subunit levels in somatic cells. Increasing amounts of bacterially-expressed and purified CgOrc2 (A),
CgOrc4 (B), and CgOrc5 (C) Mcm2 (D), Mcm4 (E), Mcm5 (F) and Mcm7 (G) were used to estimate the total number of nanograms (ng) of each ORC
subunit in the indicated number of asynchronous mammalian cells. Nanograms estimated are shown below each panel and refer to each protein
band present (top to bottom). Note that the His6-tags cause standards to migrate slower in gels relative to comparison proteins in lysates.
doi:10.1371/journal.pone.0017533.g001
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Cdc45 and Cdc6 must be considered the upper estimates of
availability for each protein within the cells. Representative blots
with the ,ng quantities detected are shown in Figure 2A&B, with
numerical results in Table S2. 10
5 CHO cells contain ,1.15 ng
in total of Cdc6 protein, which equates to ,2 molecules/100-kb,
while 10
5 cells contain ,0.26 ng of total Cdc45 protein, which
represents only ,0.35 molecules of Cdc45/100-kb. Signal
intensities for Cdc6 and Cdc45 in human and murine lysates
were very similar to those from CHO (Fig. S2B&C), strongly
suggesting that all three mammalian cell types contain similar
quantities of Cdc6 or Cdc45. Again, if one excludes the observed
additional bands for Cdc6 or Cdc45, and relies only on a single
band representing the predicted molecular weight for each
protein (e.g., p60-Cdc6, but not p62/p64), then a slightly lower
estimate would be obtained for each protein. However, taken as a
sum representing the upper estimate, mammalian cells contain
,2 total Cdc6 molecules relative to each ORC hexamer/100-kb,
which is similar to that determined in Xenopus extracts (but in the
latter Cdc6 exists at ,2 molecules/ORC/,10-kb). In contrast,
and unlike the embryonic situation, somatic cells have very low
levels of Cdc45 even though this is an upper estimate. This is in
agreement with another study that found Cdc45 to reside at low
levels in human tumor cells [38].
The low levels of Cdc45 were intriguing, and we were
concerned that we might be losing Cdc45 protein during the
preparative steps, leading to erroneous underestimations. Such loss
might be due to insolubility after lysis, poor gel separation, or over-
transfer. These potential problems might also exist for ORC and
MCM estimations. To verify this was not the case, we pelleted any
insoluble cellular proteins using high speed centrifugation, and
analyzed protein distribution between soluble and insoluble
fractions. The insoluble pellet, although not visible, was loaded
in its entirety next to 3% of soluble cell lysate (Fig. 2C). The upper
spacer gel and lower resolving gel were blotted against Cdc45,
Orc2, and Mcm2. No protein was detected in the upper gel region
or on a second membrane behind the primary membrane after
doubling transfer duration (data not shown). We did find that
,3% of Cdc45, Orc2, or Mcm2 was insoluble (Fig. 2C), but could
be efficiently separated and analyzed. Thus, we are not excluding
proteins in our analytical experiments.
We also used an alternative means to verify our Cdc45
measurements in which we immunoprecipitated Cdc45, estimated
the amount immunoprecipitated using immunoblots, and subject-
ed the immunoprecipitated Cdc45 to quantitative mass spectro-
metric (QMS) verification. Figure 2D indicates that, compared to
bacterially-generated Cdc45 standards (bac-CgCdc45, amounts
determined against BSA standards), we can recover ,1.8–2.0 ng
of Cdc45 in the immunoprecipitate (IP) from 2610
7 CHO cells.
This equates to ,27.5–30.6 fmol of Cdc45 recovered
(1 ng=15.3 fmol). We note that our IP is inefficient and fails to
IP .95% of total Cdc45. Two standard curves were generated for
QMS analysis of the IP sample, one using a synthetic CgCdc45
peptide of exact amounts, and the other using bac-CgCdc45 that
was gel-purified and trypsin-digested. The CgCdc45 tryptic
peptide, aa260-LEEEIVAR, was followed due to its high signal
intensity in pilot MS assays. The synthetic peptide had a leucine-
valine change to offset mass, allowing simultaneous determinations
in single QMS runs. QMS comparison of several amounts of bac-
Cdc45 to co-analyzed synthetic peptide of the same amounts
resulted in peak areas that were, on average, ,70% of the
synthetic peptide signal (Fig. 2E; results are plotted in Fig. 2F). As
some loss of protein occurs during tryptic digestion and gel-
extraction (but not for synthetic peptide), these results indicate that
our BSA-estimated amounts of bac-CgCdc45 are fairly accurate
(for this QMS and previous immunoblotting analyses).
To facilitate QMS sensitivity, two immunoprecipitates each
from 2610
7 CHO were combined for QMS analysis of
immunoprecipitated Cdc45 against the standard curves. Fig. 2D
predicted that the combined IP would result in a QMS
determination of ,55–60 fmol of Cdc45. As shown in Fig. 2F,
the IP sample produced a peak area of ,1.3610
7, calculated to be
38 or 53 fmol, depending on the standard curve that was
compared. Although both numbers are slightly lower than
predicted, this objective analysis strongly suggests that the
immunoblotting determinations for CgCdc45 are accurate
estimates (and that we may be over-estimating Cdc45 levels).
We conclude that mammalian cells do indeed contain very low
levels of Cdc45.
Chromatin-bound fractions of preRCs and Cdc45 during
G1 and S-phase
The molecular estimates described in the previous sections were
arrived at using total protein lysates of asynchronous cells. If the
subunits are not expressed similarly at all cell cycle stages, then we
might be underestimating protein levels in asynchronous cells.
Also, it is generally assumed that the chromatin-bound fraction of
preRCs are the functional components. To address these issues,
we determined the total preRC subunit expression levels during
G1 and S-phase, and assessed the chromatin-bound distribution of
preRCs at the G1/S transition. Chromatin-bound preRCs are
operationally defined by their resistance to extraction with non-
ionic detergents [36,39], which we will refer to as higher affinity,
while those extractable we will refer to as lower affinity (often
called ‘soluble’ in other reports). Total extracts (TCE), lower
affinity (soluble), and higher affinity (chromatin) fractions were
prepared from equal numbers of synchronized or log CHO cells
(Fig. 3). Immunoblotting against lamin and tubulin verified
effective fractionation, and BrdU pulsing indicated that G1/S
was at 9 hrs and S-phase occurred from 9–18 hrs (data not shown,
but see ref. [39]). While G2 and M-phase populations are not
represented here, CHO cells have a doubling time of ,20–21 hrs
and G2 and M-phase is 2–3 hrs (data not shown). Therefore, our
18 hr analysis covers most of the cycle.
ORC and MCM dynamics during G1 and S-phase show that
none of these subunits fluctuate significantly in total expression
during this duration (Fig. 3A&B), with the possible exception of a
small decrease in Mcm5 in early G1 (Fig. 3B). Consistent with
these findings, another study has shown that Orc2, Mcm3, Mcm4,
and Mcm5 do not fluctuate during the cell cycle in asynchronous
human cells [36]. Cdc6 and Cdc45 levels also do not significantly
fluctuate in TCE samples, although some bands for each are more
abundant in S-phase (Fig. 3C). The most notable of these is Cdc45
detected with Ab2, which suggests that we might be underesti-
mating Cdc45 levels by a factor of two with this antibody in log
cells. However, if we multiply the results in Table S2 for Cdc45-
Ab2 to accommodate this (by two), the outcome is still consistent
with that using Cdc45-Ab1 (i.e., very low). We conclude that we
are not grossly underestimating ORC, MCM, Cdc6, or Cdc45
subunit levels in log cells.
100% of Orc2, ,50% of Orc4, 100% of p60-Orc5, and none
of p45-Orc5 (Orc5T) displays a higher affinity for chromatin at
G1/S (Fig. 3A, 9 hrs). The ,50:50 Orc4 distribution has also
been seen by others [40]. The log samples, on which we
performed subunit calculations above, distribute similarly.
Importantly, the bands detected in log samples and at G1/S
display similar intensities (for TCE or chromatin), indicating that
there are similar total and chromatin-bound numbers of ORC
Mammalian PreRC Stoichiometry and Cdc45 Function
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chromatin-bound complement, a 1:1:1 stoichiometry exists
between Orc2, Orc4, and p60-Orc5 (Table S2; p45-Orc5/
Orc5T is excluded due to its non-chromatin-binding nature). We
conclude that there is an average of ,1 chromatin-bound ORC
hexamer/100-kb at G1/S.
Figure 2. Estimates of Cdc6 and Cdc45 protein levels. Increasing amounts of purified CgCdc6 (A) or CgCdc45 (B) were used to estimate the
total number of nanograms of Cdc6 or Cdc45 in asynchronous CHO cells. Non-tagged CgCdc6 was used for the Cdc6-Ab1 (probing 2) and Cdc6-Ab2
analyses. (C) CHO cells were lysed in loading dye, boiled 10 min, sonicated, and spun at high speed for 30 min. The entire insoluble pellet was loaded
alongside 3% of the soluble lysate and analyzed by immunoblotting. (D) CgCdc45 was immunoprecipitated from 2610
7 log CHO cells with chicken
anti-Cdc45. The entire immunoprecipitate was blotted against bacterially-generated CgCdc45 standards with rabbit anti-Cdc45. (E) QMS analysis was
performed on co-analyzed synthetic CgCdc45 peptide and bacterially-generated CgCdc45. (F) Standard curves were plotted using the results from E,
and the CgCdc45 immunoprecipitated from 4610
7 CHO cells was compared after QMS.
doi:10.1371/journal.pone.0017533.g002
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the subunits distributes ,50:50 between soluble and chromatin
fractions at G1/S and in S-phase, as do log samples (Fig. 3B).
Others have also shown that ,50% or less of human MCMs are
chromatin-bound during S-phase [34,36]. The band intensities for
MCM log and 9–18 hr samples are similar (for TCE and
chromatin), indicating that there are similar total and chroma-
tin-bound numbers of MCM subunits/cell in log samples, and
from G1/S through S-phase. We also collected synchronized
CHO cells at 8 hrs (,1 hr prior to G1/S) and quantified Mcm7
levels in TCE and chromatin (Fig. 3D). In agreement with our
quantitation for Mcm7 in Fig. 1, just prior to G1/S ,4–5 Mcm7
reside on chromatin/100-kb, but the fractionation just described
indicates that this shifts to ,50:50 once S-phase starts.
These results suggest that ,half of MCM hexamers may be
functional (or capable of functioning in the future) in DNA
replication at any moment in S-phase. The functional role of
chromatin-bound MCMs in DNA replication is derived primarily
from embryonic and yeast studies, where MCMs that are not
functioning in DNA replication (with lower chromatin affinity) are
blocked from entering, or exported out of, the nucleus
[4,41,42,43,44]. However, given that mammalian somatic MCMs
are nuclear during the entire cell cycle regardless of chromatin
affinities [34,39,45,46,47,48], the functional distinction between
low and high affinity MCMs in somatic cells is currently unknown.
As such, we conclude that somatic cells contain a total of 4–5
MCM hexamers per ORC/100-kb, and that perhaps ,2–3
hexamers/ORC are chromatin-bound at any moment in S-phase
(Table S2, far right columns and gray boxes). Intriguingly, the
latter resembles the embryonic system where ,2 MCM
hexamers/ORC are minimally required for uninterrupted DNA
replication [18].
Approximately 33% of total protein bands for Cdc6 and ,33–
50% of total bands for Cdc45 (with Ab1 or Ab2, respectively)
become bound to chromatin during S-phase, which is very similar
to the distributions for log samples (Fig. 3C). Again, our
,percentages here must be considered upper estimates, since we
are including all visible bands of the appropriate size ranges for
Cdc6 and Cdc45 and not purposefully drawing any preferences for
particular bands observed. The band intensities for Cdc6 and
Figure 3. Cell cycle and chromatin distributions of preRC subunits. (A–C)G 0-arrested CHO cells were released into G1, and samples were
collected at the indicated times after release. Total cell extracts (TCE) were compared to cytosolic/nucleosolic (soluble) and chromatin-bound
(chromatin) extracts by immunoblotting. Asynchronous (Log) cultures were processed identically. Extract from an equivalent amount of cells was
loaded in each case, and analyzed with the indicated antibodies. BrdU labeling was ,50% at 9 hr (G1-S transition), ,95% at 12 and 15 hrs, and ,80%
at 18 hrs (data not shown). (D) Quantitation of Mcm7 levels on total and soluble/chromatin fractions in synchronized CHO cells 8 hrs post release.
doi:10.1371/journal.pone.0017533.g003
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that there are similar total and chromatin-bound protein numbers
per cell in log samples and during S-phase. Thus, an average of
,0.53 Cdc6 and ,0.13 Cdc45 (as upper estimates) reside on
chromatin relative to each ORC hexamer/100-kb (Table S2).
However, since little is known regarding the functional distinctions
between low and high affinity forms, it is perhaps more relevant to
focus on the total levels for both proteins. Indeed, the chromatin-
bound approximations for Cdc6 may be an underestimate of the
functional requirement for Cdc6, since in Xenopus two Cdc6 are
chromatin-bound at each ORC to load MCMs, but can dissociate
to load MCMs at other ORCs [18,49]. As for Cdc45, it exists at an
extremely low level genome-wide, whether considering the total
amount (,0.35 Cdc45 per ORC/100-kb, as an upper estimate) or
the higher affinity portion (,0.13 Cdc45 per ORC/100-kb).
The same limited number of Cdc45 molecules persists
through S-phase
The results of Figure 3C showed that total Cdc45 levels
remained largely unchanged during S-phase (9–18 hr). We next
determined if this steady-state Cdc45 presence during S-phase was
derived from the same limited number of molecules that were
continually present throughout the replicative period. Synchro-
nized CHO cells were treated with cycloheximide (CHX) prior to
S-phase (Fig. 4A), or within S-phase (Fig. 4B), to block protein
synthesis, and the decay of pre-existing Cdc45 was assessed by
immunoblotting. In Figure 4B, we also separated lysates into total
(TCE), low affinity (soluble), and high affinity (chromatin) in order
to analyze different Cdc45 protein bands with varying chromatin
affinities. Compared to that seen for the highly labile c-Myc
protein, which was acutely degraded in CHX, pre-existing Cdc45
(regardless of chromatin affinity) displayed no lability and
remained present for the next 8–10 hrs, the equivalent length of
a mammalian S-phase. PCNA was also highly stable. Only a small
loss of Cdc45 protein is apparent at 20 hrs, when S-phase is
ending (Fig. 4B). The same results were obtained using either anti-
Cdc45 antibody (not shown for Ab2), and are in agreement with
another study claiming Cdc45 to have a half-life of 10 hrs [38].
Since there is no increase in Cdc45 levels during S-phase (Fig. 3C),
and Cdc45 is highly stable for the duration of S-phase, we
conclude from these results that mammalian cells have a continual
presence of a low number of stable Cdc45 molecules with which
they start, progress through, and conclude S-phase.
Cdc45 is rate-limiting for replicon usage in mammalian
cells
Based on studies in other systems, Cdc45 is likely required
stoichiometrically at replication forks for MCM function. Further,
,2 Cdc45 molecules bind MCMs per replicon in embryonic
systems [17]. Our results indicate that ,2 stable Cdc45 molecules
exist at any given moment in S-phase in somatic cells for each
,600-kb of genomic DNA, and the higher affinity Cdc45 is
present at ,2/1400-kb. Since somatic replicons appear to vary
from 50- to 450-kb, there is not enough Cdc45 to occupy all
replicons simultaneously. This suggests that Cdc45 is limiting for
replicon usage in somatic cells, and that the staggering of replicon
firing may be attributable in part to the availability of the same
limited number of Cdc45 molecules that must be reutilized
progressively throughout S-phase for the activation of later-firing
replicons.
To test the validity of these predictions, we asked if artificially
increasing Cdc45 in mammalian cells altered the dynamics of S-
phase and replicon usage. In our first approach, we attempted to
stably express exogenous HA-Cdc45 or untagged Cdc45, but
found that human, mouse, and hamster cells were significantly
reduced in their proliferative capacity when Cdc45 expression was
deregulated (Fig. 4C). In contrast, stable expression of Cdc6 did
not affect growth. These results suggest that mammalian cells can
sense, and do not tolerate, changes to the amount of Cdc45 that is
available during the cell cycle. To circumvent this problem, we
performed microinjection experiments in which bacterially-
generated His6-Cdc45 was placed directly into nuclei already in
S-phase, and the effects of the additional Cdc45 molecules on
DNA replication and replicon usage were determined. Cy3-dUTP
was co-injected and became incorporated into polymerizing DNA
during a 30 min period after injection, which served as a direct
quantifiable measure of the amount of DNA replication that
occurred. We utilized CHO cells in early S-phase to allow us to
distinguish and count replication foci produced after injections.
Introduction of ,10-fold additional Cdc45 produced a
significant increase in DNA replication activity, with Cdc45-
injected nuclei displaying ,6-fold the level of replication versus
control-injected nuclei (Fig. 4D&E raw data in Table S3).
Reducing this to ,2-fold of additional Cdc45 caused no increase
in replication activity (data not shown). The increased replication
activity could be due to faster fork movement or additional
preRC/replicon activation, or both. Computational determination
of the mean number of replication foci produced per nucleus
revealed that Cdc45-injected nuclei displayed ,3-fold the number
of replication foci versus controls (Fig. 4D). As fair comparisons,
we focused on injected nuclei displaying stage-1 S-phase foci
patterns [39] to facilitate such computational analysis (Fig. 4F).
This indicated that the additional Cdc45 molecules produced an
,3-fold increase in the number of preRCs/replicons that were
activated during the pulse period after injection. Intriguingly, a 3-
fold increase in activated preRCs/replicons would translate to a 6-
fold increase in the number of bidirectional forks, consistent with
the ,6-fold increase in mean Cy3-dUTP intensity/nucleus that
we observed (Fig. 4D). This suggests that the increased
replication/nucleus is due mostly to additional preRC/replicon
activation rather than faster fork movement. These results
demonstrate that Cdc45 is rate-limiting for DNA replication and
replicon usage in somatic cells. Further, given their stable,
persistent, and very low levels, Cdc45 molecules need to be
reutilized at later-firing replicons to achieve complete replicon
usage during S-phase, providing a molecular explanation for why
replicon usage is staggered.
Cdc45 and Mcm2 do not colocalize with active
replication sites in vivo
Although required for DNA replication to occur, and acting
presumably as a helicase, MCMs paradoxically do not colocalize
with active replication sites in mammalian cells [50,51,52,53,54].
Given that Cdc45 is a cofactor for MCM functionality [9], we
determined if Cdc45 colocalized with MCM sites and/or active
replication foci. Asynchronous CHO cells were pulsed with BrdU
to label actively replicating foci in S-phase cells, and cells were
fixed and stained by IF for the localization of Mcm2, Cdc45, RPA-
32 (single-stranded binding protein, 32 kDa subunit), or DNA
polymerase delta. Late S-phase stage nuclei [39] were visualized
for clarity of replicating foci colocalization, or lack thereof. For
RPA and polymerase analyses, detergent extraction (0.1% TX-
100) was used prior to fixation to examine the tightly-bound
complements of each factor known to associate with replication
foci. For Cdc45 and Mcm2, we performed no detergent extraction
in order to visualize the total complement (chromatin-bound and
non-bound) of each protein.
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17533Figure 4. Cdc45 protein is very stable, persists throughout S-phase, and is rate-limiting for replicon usage. (A&B) Lysates from
synchronized CHO cells analyzed by immunoblotting for Cdc45, PCNA, and c-Myc. Asterisks: background bands. 50 mg/ml cycloheximide (CHX) was
added at 8 hrs (lower panels in A), or at 12 hrs (lower panels in B). BrdU pulsing verified G1/S was at 9 hrs (not shown). For each no-CHX/CHX pair
analyzed, data was obtained from a single immunoblot. (C) Summary of results for colony forming assays. Data are representative of three assays for
each with nearly identical results. (D) Graph of results for Cdc45 microinjection experiment. Means of information from 25 most intense, early-S stage
nuclei for each condition were plotted +/21s.d. Raw data is in Table S2. (E) Original confocal scans of fields after microinjection, using identical
settings for image acquisition. (F) Close-up examples of early-S injected nuclei for each condition that were used for foci and intensity computation.
doi:10.1371/journal.pone.0017533.g004
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replicating foci, as expected (Fig. 5A&B). In contrast, Mcm2
(chromatin-bound and non-bound) does not colocalize with
replicating sites and even appears excluded from such sites
(Fig. 5C, note arrowheads showing replication foci clearly lacking
Mcm2), consistent with previous studies [50]. Similarly, Cdc45
(chromatin-bound and non-bound) does not colocalize with
replication foci and seems likewise excluded (Fig. 5D, note
arrowheads). Although only one representative cell is shown in
Fig. 5D, multiple fields each containing hundreds of cells showed
similar results, and other stages of S-phase nuclei showed similar
findings (data not shown). However, in the majority of cells, Cdc45
does colocalize significantly with Mcm2 (Fig. 5E), as predicted for
an MCM cofactor. The above experiments all utilized Cdc45 Ab1
(made in rabbit), but very similar results were obtained using
Cdc45 Ab2 (made in chicken; data not shown). We conclude from
these findings that although Cdc45 is rate limiting for replication
foci usage (Fig. 4), it is not noticeably localized to replicating sites.
Thus, Cdc45 and Mcm2 are required for DNA replication to
occur, but (as discussed below) may provide a necessary function at
some distance from the sites where DNA replication is actually
occurring.
Discussion
Embryonic versus somatic replication dynamics
Sperm chromatin in Xenopus embryonic extracts is replicated
very efficiently over an ,1 hr duration from small 10-15-kb
replicons. The preRC components are abundant in the extracts,
allowing assembly of a preRC at an ORC within each 10–15-kb
replicon. As described above, such preRCs contain 20–50 MCM
hexamers that attract 1–2 Cdc45 molecules during initiation of
replication. This frequency of preRCs and excess MCM targets for
Cdc45 contribute to the efficiency and small replicon size in the
embryonic system. Although there have been exceptions identified
and research into mammalian origin dynamics is constantly
evolving, the initiation of DNA replication in somatic cells is often
very inefficient, with origins firing in some cases only once in 3–4
cell cycles [29,55,56]. In addition, somatic origins often corre-
spond to broad zones of potential sites, any one of which is used
extremely rarely [27,55,57,58,59,60,61], and replicons in somatic
cells appear to be, on average, ,10-fold larger than embryonic
replicons, varying in size from 50- to 500-kb or more
[23,24,25,26,27,28,61]. The larger nature of somatic replicons
(when averaged) correlates with the fact that somatic cells require
,10-fold longer to duplicate their genetic content relative to the
embryonic system. We demonstrate here that, as for the
embryonic system, the availability and dynamics of preRC
components provide molecular explanations for these biological
characteristics of somatic DNA replication.
Somatic preRC stoichiometry, density, and replicon size
Although it is important to note that our results were obtained
primarily using CHO cells as the model system, with additional
tests on human HeLa and Wilson cells and mouse fibroblasts, the
collective findings presented herein strongly suggest that mamma-
lian somatic cells contain approximately 1 ORC hexamer, ,2
Cdc6, and ,4–5 total MCM hexamers, on average, for each 100-
Figure 5. Cdc45 and Mcm2 do not noticeably colocalize with actively replicating sites in vivo. Asynchronous CHO cells were used in all
panels. (A–D) BrdU was pulsed for 30 min and cells were fixed and stained with the indicated antibodies, and examined by IF UV-microscopy. Wide
field (shown) and confocal microscopy were used and gave similar results. DAPI was used to stain nuclear DNA. Representative cells are shown. (E)
Confocal microscopy was used to determine the colocalization of Cdc45 and Mcm2. Three examples are shown that are representative of the majority
of cells. Chicken anti-Cdc45 (Ab2) and rabbit anti-Mcm2 (Ab3) were used in panels C–E.
doi:10.1371/journal.pone.0017533.g005
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ORC levels) in somatic cells is ,10-fold less than the embryonic
situation. This offers one explanation for why somatic replicons
are ,10-fold larger and S-phase is ,10-fold longer than in
embryonic extracts. Interestingly, each 300-kb region, represen-
tative of the size of larger replicons, would average ,3 preRCs
(Fig. 6A, right side). Although preRC density may vary throughout
the genome to account for smaller replicons, this also suggests that
somatic cells may contain unused, dormant preRCs (both concepts
discussed below). Consistent with the latter, yeast preRCs form at
inactive sites [22,62], and there are more predicted ORC/preRC
sites than functional origins, with ,one in five origins being
activated to replicate the yeast genome [63,64]. Further,
embryonic chromatin contains extra preRCs by virtue of their
excess of MCM hexamers, some being used in initiation, while
others are dormant and used under stress conditions [20].
Another influence on somatic replicon size is the ratio of Cdc45
to preRCs. Studies in yeast and embryonic extracts have indicated
that Cdc45 likely acts stoichiometrically for MCM functionality at
forks, with 1–2 Cdc45 used per bidirectional fork pair
[9,10,12,17]. There is enough Cdc45 in embryonic extracts to
provide 1–2 Cdc45 per preRC, producing 10–15-kb average
distances between functional origins/preRCs. However, somatic
cells have ,2 Cdc45 available for every ,600-kb, and only ,2
chromatin-bound/,1400-kb. This equates to ,2 Cdc45 per ,6
preRCs, or ,2 chromatin-bound Cdc45 per ,14 preRCs (latter is
modeled in Fig. 6B). As such, the average somatic inter-origin
distance (i.e., replicon size) is considerably larger than the
embryonic situation.
Reconciling the presence of smaller replicons in somatic
cells
Mammalian replicons can be as small as 50-kb, and under
replicative stress conditions inter-origin distances can be as little as
,15–20-kb [23,25,27]. Such findings suggest that preRC density
should be one for each ,50-kb, and perhaps as often as 20-kb.
There are at least two explanations that can reconcile these
findings. First, there is no formal evidence that all members of the
preRC are located adjacent to one another in a discrete complex.
Indeed, one study has shown that mammalian MCMs are not
located on the same DNA fragment as ORC [53]. As such, the 4–
5 total MCM hexamers/100-kb may not reside at ORC sites,
which suggests an intriguing model. If MCMs are initially loaded
at ORC sites, but for unknown reasons finally reside at multiple
distinct sites throughout the 100-kb region, then one MCM
hexamer would reside on somatic chromatin each ,20-kb. In this
situation, it would not be a complete preRC, but rather an MCM
hexamer capable of unwinding DNA, every 20-kb. An alternative
explanation derives from the fact that we have only determined
the average preRC density to be one/100-kb. It may be that in some
regions of the genome preRC density is one/20-kb, while in other
regions it is one/400–500-kb. Indeed, conditions such as
chromatin structure or transcription likely influence where preRCs
can form (or not form). Thus, depending on how one models
preRC distribution and stoichiometry from the approximate
averages determined herein, seemingly opposing findings can be
reconciled.
Somatic origin firing is often inefficient relative to
embryonic metazoan origins
Embryonic preRCs are spaced ,10-kb and contain 20–50
MCM hexamers that attract ,2 Cdc45. Interestingly, a similar
ratio of Cdc45:MCM hexamers exists in somatic cells where ,24–
30 MCM hexamers are present for each ,2 Cdc45 molecules.
Such a ratio is essentially the same even when considering the
chromatin-bound complement of somatic Cdc45 and MCMs.
Thus, the ratio of Cdc45 to MCM hexamers has been maintained
over developmental time. However, this physical presence of
Cdc45:MCMs in somatic cells is spread over ,600-kb. The same
600-kb span of the embryonic genome contains ,120 Cdc45
targeting ,1200–3000 MCM hexamers. Thus, the abundant
embryonic Cdc45 protein is presented with a high density of
Figure 6. Models for preRC architecture, distribution, and usage in somatic cells. (A) Each 100-kb of somatic genomic DNA has, on average,
one preRC comprised of one ORC hexamer, ,4–5 total MCM hexamers (six shown for each preRC), and two Cdc6. Potentially larger replicons of 300-
kb average ,3 preRCs. (B) Cdc45 is extremely limiting, suggesting that only 1 in 14 preRCs/1400-kb, on average, can contain two chromatin-bound
Cdc45’s at any moment in S-phase. (C) Replicons fire in clusters and in a staggered manner. The very low, stable, and rate-limiting Cdc45 levels require
that replicon cluster A wait until Cdc45 becomes available from previously-replicated clusters. Each replicon in C is shown with only one preRC for
simplicity.
doi:10.1371/journal.pone.0017533.g006
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lower density of MCM targets on a per genomic region basis.
Because of this, the ability of any specific somatic preRC (with an
average of 4–5 MCMs) to be recognized on a genome-wide basis
by low levels of Cdc45 is severely reduced relative to embryonic
conditions, resulting in a decreased efficiency of preRC/origin
usage in somatic cells. In agreement with this, the efficiency of
Cdc45 recruitment to yeast origins/MCMs correlates directly with
their firing efficiencies [22]. In addition, a recent study has shown
that S. pombe yeast Cdc7 is limiting for initiation of DNA
replication, indicating that other preRC (or pre-IC) subunits
may be limiting in mammalian cells beyond Cdc45 [65].
Further compounding the above situation, mammalian ORC
exhibits very little DNA-binding specificity [66]. As such, Cdc45 is
presented with a low density of apparent ‘moving targets’ in terms
of where preRCs/MCMs are established by ORC. This further
reduces the chances (and efficiency) of any particular DNA site
within a larger region from being utilized in any one S-phase, and
may comprise part of the reason why mammalian origins are often
composed of zones of distributed initiation sites [57,58,59,67]. It is
also important to keep in mind that origin efficiency in somatic
cells is likely to be governed by issues beyond preRC stoichiom-
etry. For example, complex chromatin structure (e.g., heterochro-
matin) and transcriptional domains, both of which are of limited or
no influence to embryonic chromatin, may influence origin firing
in somatic cells. In addition, small intergenic regions, such as that
comprising the lamin B2 origin locus, may increase the efficiency
of origin usage by focusing preRC subunits into a smaller region
(i.e., increasing preRC/MCM density), resulting in an enhanced
ability of Cdc45 to find such complexes/MCMs. Again, the
preRC stoichiometries presented herein only provide ‘building
blocks’ for modeling preRC structure and origin dynamics that
must be factored into the larger chromatin and transcriptional
environment within cells.
Cdc45 is rate-limiting for replicon usage in somatic cells
Relative to other preRC components, the extremely low level of
stable Cdc45 present at any moment in S-phase suggested that
Cdc45 might be rate-limiting for replicon/preRC activation.
Indeed, reduction of Cdc45 in embryonic extracts reduces DNA
replication, consistent with it being rate-limiting [17]. However, if
Cdc45 acts enzymatically, and not stoichiometrically, then even
low levels of Cdc45 might not be rate-limiting, and its removal
would also hinder replication efficiency. We show conclusively that
somatic Cdc45 is indeed rate-limiting for replicon usage, and by
derivation preRC activation. Introduction of additional Cdc45
molecules via microinjection causes an ,3-fold increase in the
number of active replication foci and an ,6-fold increase in the
overall level of DNA replication within nuclei. This ratio of
additional foci to replication activity is consistent with the injected
Cdc45 activating 3-fold the number of preRCs, and thus
producing 6-fold the number of forks, that would otherwise have
been active. Such a finding also supports the contention described
above that the ratio of Cdc45 to MCMs influences the efficiency of
preRC/origin usage. Intriguingly, although we can artificially
introduce additional Cdc45 during S-phase itself, followed by
acute changes to replicon/preRC activation, our colony forming
assays indicate that mammalian cells do not tolerate permanent
changes to Cdc45 expression during cell cycling.
Our results are in close agreement with those shown in fission
yeast where overproducing Cdc45 causes an increase in DNA
replication activity at a number of origins [22], indicating that
Cdc45 is rate-limiting for DNA replication in that system.
Although the relative abundance of Cdc45:MCM subunits is not
known in such yeast, the authors proposed that Cdc45 is therefore
likely present at low (i.e., limiting) levels in cells, which prevents
efficient origin usage. We show here that in somatic cells both
situations are true. Cdc45 is stable and present at low levels that
are limiting to replicon/preRC activation at any moment in S-
phase. Additional replicons/preRCs can be acutely activated upon
introduction of more Cdc45, indicating that Cdc45 is minimally
one factor that established preRCs wait for in order to become
activated. However, as described above, chromatin accessibility,
transcriptional domains, or other as yet unknown limiting factors
may also control replicon usage.
Replicon clusters and staggering
DNA replication in Xenopus extracts and in mammalian cells
occurs in replicon clusters, with clusters replicating in a staggered
manner [20,23,25]. In somatic mammalian cells, the low level of
stable and rate-limiting Cdc45 molecules present throughout S-
phase provides a molecular explanation. If early-firing replicon
clusters are occupied by stoichiometrically required Cdc45 (e.g.,
cluster B in Fig. 6C), then there is not enough Cdc45 for other
clusters to be simultaneously occupied (e.g., cluster A). Such later-
firing replicon clusters will remain inactive until Cdc45 becomes
available from the limited, stable pool of Cdc45 acting at earlier
clusters. Thus, complete replicon usage during S-phase can be
achieved only by re-utilizing the small number of rate-limiting
Cdc45 molecules, which staggers replicon usage. We propose a
‘function-and-run’ mechanism where Cdc45 leaves completed
replicon clusters, perhaps from forks that have merged (while those
at the cluster periphery continue elongating), and migrates to later-
firing clusters/replicons (Fig. 6C). Consistent with this model,
Cdc45 can re-enter pre-established forks/preRCs during S-phase
in both yeast and Xenopus [9,12].
Reconciling the low level of MCMs with the existence of
excess, dormant MCMs
As in the embryonic system, mammalian somatic cells contain
an excess of MCMs that are dormant during S-phase, but become
functionally required under replicative stress [20,25,68]. Total
levels of somatic MCMs can be reduced by perhaps ,75% with
no adverse effect on DNA replication [25]. This indicates that
excess MCMs exist in somatic cells and appears to be inconsistent
with our results showing that MCMs are present at low levels
relative to the embryonic situation. However, these findings can be
reconciled if one considers the effect on preRC architecture after a
reduction of somatic MCMs as reported by others.
Reducing the 4–5 MCM hexamers/ORC that we estimated by
,75% produces ,1–2 MCMs/ORC. In Xenopus extracts, 2
MCM hexamers/ORC are minimally required for DNA replica-
tion [18], and our estimations suggest that ,2 out of the 4–5 total
MCM hexamers may be actively utilized (i.e., higher affinity for
chromatin) at any one moment in S-phase relative to each ORC
(green circles for higher affinity MCMs in Fig. 6). Therefore, it
seems likely that a somatic preRC could function with ,75% of its
MCM complement absent. Further, if a larger replicon of 200–
300-kb contains multiple preRCs (e.g., 2–3 preRCs as described
above), and only one preRC is required for activation, then even
more MCMs would be present and could be removed without an
adverse effect on the replicon. Indeed, a recent study has shown
that mammalian cells can proliferate with ,90% of their MCM
complement reduced [68]. However, such cells cease dividing in a
few generations and accumulate DNA damage, and our results
would indicate that this is because a threshold has been reached
where preRCs have been reduced to less than 2 available MCM
hexamers/ORC. Thus, from another perspective, somatic MCMs
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numbers per genome as that in embryonic systems. Intriguingly, if
somatic replicons do indeed contain ,2–3-fold the preRCs/
MCMs they need for functionality, then this may explain why our
Cdc45 microinjection experiments produce an ,3-fold increase in
foci/preRC activation, but no increase beyond this even though
we have provided ,10-fold excess of Cdc45/nucleus.
Paradoxical lack of Cdc45 in replication foci
There is a longstanding paradox in mammalian somatic cells
that, although presumably required for helicase functionality at
forks during DNA replication (i.e., within replisomes), MCMs are
not localized by immunofluorescent staining techniques to actively
replicating foci (i.e., BrdU incorporation sites), but are instead
clearly present at distal DNA sites throughout the genome that
have not yet replicated [50,51,52,53,54]. We now show that in
addition to MCMs, Cdc45 is also not noticeably present at actively
replicating sites in vivo. We do find that Cdc45 localizes to at least a
subset of Mcm2 sites, consistent with its presumptive role as an
MCM cofactor [9,69]. RPA, PCNA, and DNA polymerase delta
are clearly present in replicating foci [ref. [50] and results herein],
indicative of the presence of ssDNA at the forks in the foci. Given
the clear presence of such fork proteins in replication foci, the lack
of clearly visible MCMs and Cdc45 within replicating foci creates
a paradox in which MCM-Cdc45 complexes facilitate DNA
unwinding while not seemingly localized directly at forks within
replication foci. In addition, MCM-Cdc45 are known to interact
with DNA polymerases via Mcm10 [70,71], which should place
them within replication foci (replisomes). We suggest some
possibilities below that may reconcile these paradoxical findings.
We concede that a limitation of our immunofluorescence assays
may be that the absence of Cdc45 at replication foci derives from a
lack of Cdc45 epitopes in the foci, but this would need to be true
for both of the polyclonal antibodies we tested (and similarly true
for the multiple MCM studies described above that arrive at the
same conclusion). Also, the timing of fixation relative to when/
where DNA replication is occurring might contribute to a seeming
lack of colocalization, although this does not affect colocalization
of RPA, PCNA, or DNA polymerase with BrdU foci. However, a
possible explanation for this apparent distal localization paradox
may be that MCM-Cdc45 complexes do indeed function directly
at forks in the foci, but also simultaneously associate with and
provide an unknown function during DNA replication at distal
DNA sites (see below). Alternatively, MCM-Cdc45 complexes
might actually function at a significant distance, in terms of DNA
length, from replication forks themselves, but are brought into
replisome proximity during DNA replication via a coordinated
looping process, perhaps anchored to replisomes by Mcm10
[70,71]. In either situation, it is entirely possible that large-scale
chromosomal rearrangements during fixation steps for IF imaging
and BrdU analysis, as can occur [72], might cause an artificial
dissociation of Cdc45/Mcm2 from replication foci due to such
distal DNA interactions, leading to the observation that MCM-
Cdc45 complexes are not physically present in replication foci.
It is well known that in vitro dsDNA strand separation assays
indicate that MCMs have the potential to function directly as a
helicase [73,74], and at least one report has suggested that Cdc45
and MCMs are present at replication forks in metazoan
embryonic extract replication assays [69]. The latter study utilized
a streptavidin steric hindrance method to accumulate active
replication forks at one site on a plasmid, along with accumulation
of proteins present in replisomes at such forks. Cdc45 and MCMs
were enriched at these accumulated forks, suggestive of their
functional presence within active forks [69]. However, an alternate
interpretation of this study is that Cdc45 and MCMs might have
been initially functioning at distal sites (e.g., at the streptavidin site
itself) from where replisomes were functioning on the plasmid, and
the streptavidin caused replisomes to accumulate at this site, which
then overlapped some of the Cdc45 and MCM complexes (i.e.,
they caught up with one another). Consistent with this alternate
interpretation, MCMs are indeed known to interact with a
significant portion of plasmid DNA sequences in Xenopus laevis
embryonic extracts [75].
It must also be kept in perspective that the in vitro helicase
assays used to demonstrate the ability of purified MCMs to
separate dsDNA oligonucleotides [73,74] may not be a true
indicator of MCM function in vivo.A l t h o u g hM C M sd oi n d e e d
separate these structures (i.e., act as helicase), as carefully
discussed in a recent report by the Diffley lab [76], the RuvB
protein involved in recombination, and which does not actually
function as a helicase, also separates dsDNA strands in this
helicase assay as a result of its translocase activity. Thus, this in
vitro helicase assay itself, while consistent with a role for MCMs in
direct fork functionality, does not conclusively validate that
MCMs do indeed function as such under normal biological
conditions. However, such assays clearly indicate that MCMs
possess translocase activity, recently confirmed using other
approaches [76]. Intriguingly, the latter study also showed that
yeast MCMs assembled on circular plasmid DNA do not possess
an intrinsic ability to melt dsDNA, but do translocate on DNA
molecules [76]. Despite these caveats, if a fixation artifact is
indeed concealing the fact that mammalian MCM-Cdc45 is
localized at forks during DNA replication, then it becomes much
easier to reconcile these findings. However, if MCM-Cdc45
complexes do function exclusively at DNA sites that are separated
a significant distance from forks themselves, whether or not they
are brought into physical proximity within replisomes during
replication (via Mcm10 interactions/looping), then how might
their functionality at a distance facilitate DNA replication?
We favor two possible explanations that are not mutually
exclusive with one another, and that incorporate the translocase
activity of MCMs. First, as suggested by Laskey and Madine [54],
MCM-Cdc45 complexes may function as a fixed translocase at
distal sites, producing DNA unwinding within replication foci due
to rotation and resultant torque forces applied to the DNA helix at
a location far from the fork/ssDNA itself (rotary pump model).
However, this should not be misinterpreted to imply that ssDNA is
created the entire distance between distal MCMs and the forks.
Second, we propose that MCM-Cdc45 might also facilitate fork
unwinding from a distance by translocating along DNA (or the
DNA moves through fixed MCM translocases, to be consistent
with the rotary pump model) and altering higher order chromatin
structure indirectly with associated chromatin modifying enzymes.
In such a situation, simpler less condensed chromatin (e.g., ‘beads
on a string’) would be presented to the replisomes in a coordinated
manner. Such decondensation of chromatin structure may
secondarily be accompanied by changes to DNA structure/
writhing, resulting in a more unwound DNA topological state at
distal forks within replication foci. Indeed, MCMs interact strongly
with histone H3 [77,78], and with chromatin modifying enzymes
[77]. In addition, we have shown that Cdc45 promotes DNA
replication in part via changes to higher order chromatin
decondensation [37], which could occur at distal sites from forks.
Either possible mechanism might thus produce "indirect helicase
functionality at a distance", and perhaps provide other function-
ality. Clearly, further research is necessary to explain molecularly
the paradoxes observed for MCMs/Cdc45 in mammalian somatic
cells.
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Cell Culture, synchronization, and transfections
Chinese hamster ovary (CHO) [39], Wilson human Burkitt’s
lymphoma line [79], NIH3T3, HeLa, and SW480 colon
carcinoma cells (latter three cell lines available from ATCC) were
maintained in MEM with 10% Fetal Clone II (Hyclone). CHO
cells were arrested in G0 by isoleucine starvation [39]. Transfec-
tions used Fugene-6 (Roche) and equal amounts of plasmids
expressing indicated cDNAs in pcDNA3-based vectors co-
transfected with equal amounts of pTK-hygro. Colony selection
in hygromycin (400 mg/ml) lasted 10 days.
Protein purification
The following were expressed with His6-tags in BL21-
CodonPlus-DE3-RIPL bacteria (Stratagene): CgOrc2, CgOrc4,
CgOrc5, HsMcm2, HsMcm4, HsMcm5, HsMcm6, HsMcm7,
CgCdc6, and CgCdc45 (Cg, Cricetulus griseus, Chinese hamster).
Except for HsMcm2 and CgCdc6, proteins were largely insoluble
and required purification under denaturing conditions using Talon
columns (Clontech). Non-tagged CgCdc6 was also purified over
HiTrap Sp FF and HiTrap Heparin HP columns (details
available). Purified proteins were separated in gels alongside
ultrapure BSA standards (Biorad), and coomassie-stained bands
were compared to determine the amount of each protein isolated.
Antibody production
Polyclonal rabbit antibodies were produced by Covance, Inc.,
and polyclonal chicken antibodies (where indicated) were
produced by Aves Labs. All were used at 1:500 unless specified.
Anti-CgOrc2 (Ab3; 1:100 for Westerns), anti-Mcm2 (Ab3; 1:50 for
IF), anti-HsMcm4 (Ab1), anti-HsMcm5 (Ab2), anti-CgCdc6 (Ab2),
anti-CgCdc45 (Ab1), chicken anti-HsMcm4 (Ab2), and chicken
anti-CgCdc45 (Ab2; 1:50 for IF). Purified, antigen-specific
antibodies: whole antisera were incubated with full-length antigens
immobilized on blotting strips, then eluted [80].
Additional antibodies
All antibodies were generated in rabbits and used at 1:500
unless specified. From BD Biosciences: mouse monoclonal anti-
HsOrc4 (#611171; conserved domain for Hs and Cg), anti-
HsOrc5 (#559267; identical C-term epitope except for one
residue between Hs and Cg), and anti-HsMcm2 (Ab1; #559542).
Anti-HsOrc2 (Ab1), anti-HsOrc2 (Ab2), anti-HsMcm2 (Ab2), anti-
HsMcm5 (Ab1), and anti-HsMcm7 (Ab1) were provided by Rolf
Knippers (Konstanz, Germany). From Santa Cruz: anti-HsCdc6
(Ab1; sc#8341), mouse anti-Mcm7 (Ab2; sc#9966), and goat anti-
polymerase delta (1:50). From Upstate: anti-Hs-cyclin A (1 mg/ml).
From Calbiochem: mouse anti-lamin A/C, anti-tubulin, and anti-
HsPCNA (1.5 mg/ml). Anti-RPA-32 rat polyclonal was from Cell
Signalling (1:100).
Protein quantitation and fractionation assays
Cells were scraped off plates into cold PBS (without trypsiniza-
tion to prevent protein loss), then lysed and boiled immediately in
loading dye. Prior to such lysis, an aliquot of scraped cells was
removed to determine the total number of cells collected. The
aliquot of cells was resuspended in 10 mM HEPES, 10 mM
EDTA, on ice for 15 min to yield single-cell suspensions without
using trypsin. Cell numbers were determined with several
hemacytometer readings of multiple fields, done independently
by two individuals (all within 5%). Cells were collected on different
days to generate two independent lysates for quantification. For an
antibody used two times to quantify, each assay was done on
independent lysates. Immunoblotting and immunoprecipitation
were performed using standard techniques. Fractionation into
soluble and chromatin lysates was done as described [39].
Quantitative mass spectrometry
Protein bands were excised from gels, dehydrated, reduced with
tris(2-carboxyethyl)phosphine, alkylated with iodoacetamide, and
digested overnight with trypsin. Resultant peptides were extracted,
concentrated, and selected for multiple reaction monitoring
experiments using a nanoflow liquid chromatograph (U3000,
Dionex, Sunnyvale, CA) coupled to a triple quadrupole mass
spectrometer (TSQ Quantum Ultra, Thermo, San Jose, CA). A
synthetic peptide was spiked into each sample prior to QMS.
Peptides were separated at 300 nl/min by reverse phase
chromatography (LC Packings C18 Pepmap, 75 um ID615 cm)
using a 25 minute gradient from 5% A to 50% B (A: 2%
acetonitrile/0.1% formic acid; B: 90% acetonitrile/0.1% formic
acid). Three sequence-specific transitions (y- ions) were monitored
for each peptide.
Microinjections and computational analyses
Soluble His6-CgCdc45 was purified from bacteria and diluted
in PBS containing 100 mM Cy3-dUTP (Amersham). The control
was from bacteria transformed with His6-vector (both samples
contained residual bacterial proteins). The final concentration of
Cdc45 injected into CHO nuclei was 45 ng/ml. An Eppendorf
FemptoJet and InjectMan instrument was used on a Nikon Eclipse
TE2000-S microscope outfitted with a QImaging Retiga 1300
CCD camera and a LWD 20x/0.40 NA lens. Injections used 300
hPa for 0.4 sec, resulting in ,1 picoliter injected/nucleus. Thus,
,45 fg of Cdc45 was injected/nucleus, which is ,10-fold the
existing Cdc45 per CHO cell (,3 fg/nucleus based on Table S2).
Equal numbers of CHO nuclei were injected and fixed 30 min
later with 2% formaldehyde. Unincorporated Cy3-dUTP was
washed away. Images of injected cells were obtained using a Leica
TCS SP5 AOBS confocal microscope and LAS AF software (ver
2.1.0), with no file compression. All settings were identical during
image acquisition for valid intensity quantification comparisons.
Images of individual nuclei were obtained for clarity using 2.5X
optical zoom. For foci counting, the gain was reduced on Cdc45-
injected nuclei prior to separate image acquisition. Intensity and
foci analysis was done using Image Pro Plus (ver 6.2) (Media
Cybernetics, Inc.). Identical threshold settings and measurements
were used to generate the mean intensity and foci data. Foci were
defined as an object with an intensity value of at least 100
(dynamic range) and an area of between 10–600 pixels. Each
nucleus was examined independently. No additional post-process-
ing manipulations were done to enhance images.
Immunofluorescence
Standard methods were used to process cells for indirect
immunofluorescence and BrdU labeling [81]. Wide field micros-
copy utilized a Zeiss Automated Upright Fluorescent microscope,
and confocal images were collected using a Leica TCS SP5 Laser
Scanning microscope. Adobe Photoshop software was used to
process and arrange images.
Formula, molecular weights, and genome sizes
The formula used to quantify the number of protein molecules
was: (ng of unknown protein)66.02610
23/(molar weight of protein
in ng)6(number of cells analyzed), which represents the number of
molecules of each protein per cell. MWs were used based on the
atomic mass of amino acids in each protein (in Daltons):
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Mcm5=82,300; Mcm7=81,300; Cdc6=62,300; Cdc45=65,400.
Although Orc5 is predicted to be 50,300 Da, the apparent sizes of
two Orc5 isoforms were used: ,45 and 60 kDa; also seen by others
[32]. The Chinese hamster diploid genome is ,7610
9 bp (http://
www.cbs.dtu.dk/databases/DOGS), and was used for calculations.
Mouse (,6.8610
9 bp) and human (,6.8610
9 bp) diploid genomes
are similar. There are ,70,000 100-kb DNA segments per diploid
mammalian somatic cell genome.
Supporting Information
Figure S1 Characterization of antibodies. Total cellular
extracts (TCE), chromatin-enriched (Nucl), or total extracts from
cells transiently-transfected with LacI-tagged subunits were used.
Expected sizes for endogenous ORC, MCM, Cdc6, or Cdc45 are
indicated with MW. Expected sizes of LacI-tagged versions are
also indicated. For MCMs, the lower arrow is the endogenous, and
upper arrow is the LacI-tagged version. The anti-Mcm7 also
recognizes LacI-HsMcm7 (not shown). In C, An IP-Western
verified Cdc6-Ab1 and Cdc6-Ab2 specificities. Anti-Cdc6 Ab2
recognizes three protein bands, arbitrarily assigned p60, p62, and
p64 (likely due to ubiquitinylation and/or phosphorylation as
described in the text). LacI-CgCdc6 is p100. Transfection
experiments using shRNA constructs directed at CgCdc45 and
CgCdc6 were undertaken in CHO cells to determine which exact
bands corresponded to Cdc45p and Cdc6p, respectively, but were
inconclusive. For Cdc45 in particular, several days of shRNA
expression failed to effectively reduce expression of Cdc45 protein
bands, which we attribute at least in part to the noticeable stability
of Cdc45 protein as indicated in our results in Figure 4.
(TIF)
Figure S2 Protein estimations for hamster, human, and
mouse Orc2, Orc4, Orc5, Cdc6, and Cdc45. Increasing
amounts of bacterially-expressed and purified CgORC subunits
(A), CgCdc6 (B), and CgCdc45 (C) were used to estimate subunit
levels in the indicated number of asynchronous CHO, 3T3, HeLa,
or Wilson cells. ng estimated are shown below each panel and refer
to each protein band present. Representative immunoblots are
shown.
(TIF)
Table S1 Antibodies used in this study. For sources: com,
commercial; RK, Rolf Knippers laboratory; here, generated for
this study; as, antiserum. Purified indicates that the antibodies
were affinity-purified against the antigen, or for commercial
derivatives are purified immunoglobulins. If a protein is listed
under Immunogen without any peptide or domain specification,
then full-length protein was used as the immunizing antigen. If
full-length purified proteins for immunizing contained tags, then
such tags are listed in the name of the protein.
(TIF)
Table S2 Quantification results for preRC subunits in
somatic Chinese hamster ovary (CHO) cells. Superscript
definitions: (a) Obtained from CHO data, +/2 the estimated ng
errors in reading the blots. (b) p60 and p45 Orc5 isoforms were
analyzed together on the same two blots, not four blots. (c) ORC
averages do not include the p45-Orc5 data. (d) The ,percentage
of each preRC subunit chromatin-bound at 9-hr in the
immunoblots of Fig. 3. (e) One of each of the three blots analyzed
included non-tagged CgCdc6. ND, not determined; N/A, not
applicable; NS, not shown.
(TIF)
Table S3 Raw data for 25 most intense, and measur-
able, microinjected nuclei for each condition. Early-S
(stage-1) nuclei were used for these analyses to facilitate fair and
equal computations across conditions. The mean overall Cy3-
dUTP intensities and mean number of foci were determined as
described in Methods. Errors are +/2 1 standard deviation.
(TIF)
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